These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25502016

  • 1. Extracorporeal shock wave therapy for injection site panniculitis in multiple sclerosis patients.
    Stieger M, Schmid JP, Yawalkar N, Hunziker T.
    Dermatology; 2015; 230(1):82-6. PubMed ID: 25502016
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A case of septal panniculitis secondary to interferon treatment.
    Ozuguz P, Kacar SD, Karaca S, Tokyol C.
    Cutan Ocul Toxicol; 2014 Dec; 33(4):351-2. PubMed ID: 24641120
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L, Dummer R, Burg G, Schmid-Grendelmeier P.
    Eur J Dermatol; 2002 Dec; 12(2):194-7. PubMed ID: 11872423
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate (Copaxone) injection for the treatment of multiple sclerosis.
    Soós N, Shakery K, Mrowietz U.
    Am J Clin Dermatol; 2004 Dec; 5(5):357-9. PubMed ID: 15554737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ, Cowan BJ, Hashimoto SA.
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y, Kawachi Y, Furuta J, Otsuka F.
    Eur J Dermatol; 2008 Mar; 18(5):579-82. PubMed ID: 18693165
    [Abstract] [Full Text] [Related]

  • 14. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
    Meca-Lallana JE, de Mingo-Casado P, Amorin-Díaz M, Martínez-Navarro ML, Barreiro AF.
    Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
    Weise G, Hupp M, Kerstan A, Buttmann M.
    J Clin Neurosci; 2012 Sep; 19(9):1312-3. PubMed ID: 22721889
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies.
    Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M.
    Eur Neurol; 2013 Sep; 70(1-2):35-41. PubMed ID: 23689307
    [Abstract] [Full Text] [Related]

  • 20. [Logistics and description of treatment technology (the protocol for using disease modifying drugs--DMD)].
    Federal service on surveillance in healthcare and social development (Roszdravnadzor).
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Sep; 111(2 Pt 2):93-8. PubMed ID: 21916163
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.